Scientific Publishing
The AACR celebrated one hundred years of scientific publishing during a reception for journal editors at the AACR Annual Meeting.

A Century of Disseminating World-Class Cancer Research

The 100th anniversary of the AACR’s publishing program and the 75th anniversary of its journal Cancer Research were commemorated at the AACR Annual Meeting with a special display of publication milestones.

In 1916, the Editorial Committee of the AACR launched The American Journal of Cancer, the first cancer journal published in English. Over the past hundred years, the AACR scientific publishing program has provided a forum for the most innovative cancer science, expanding to eight journals to encompass the full spectrum of basic, translational, clinical, and epidemiological research.

Celebrating the AACR’s Scientific Publishing Centennial

AACR journals commemorated a century of scientific publishing in 2016 with a special walk-through exhibit at the Annual Meeting in New Orleans. The display featured classic historical articles from the first few decades of AACR publications, highlighting the AACR’s role in establishing the foundations of cancer science. Landmark studies published in the early editions of AACR journals included the following:

  • An extensive study of a family with a high degree of cancer occurrence that established the inheritability of some cancers, such as colorectal and endometrial cancer (Warthin, 1925).
  • The first paper published in the cancer literature identifying substances in tar that cause cancer (Burrows, et al., 1932).
  • The first English-language reports of estrogen inducing mammary tumors in mice (Lacassagne, 1936).

Cancer Research: The Voice of the Cancer Community for 75 Years

The AACR also marked the 75th anniversary of its flagship journal, Cancer Research, in 2016. This milestone was commemorated with a special historical publication distributed to attendees of the Annual Meeting. The journal also published commentaries throughout the year on seminal articles published in the journal that arguably formed the basis of modern cancer research, including the following:

  • One of the first studies to report that the tumor-promoting effects of a high-fat diet could be directly attributed to caloric intake (Lavik and Baumann, 1943).
  • A paper that provided the critical link between cancer incidence and smoking (Wynder et al., 1953).
  • An analysis of United Nations research on the consequences of atomic testing a year before the United States, United Kingdom, and Soviet Union signed the Limited Test Ban Treaty (Upton, 1962).
  • A critical paper demonstrating the importance of the vasculature to tumor growth, focusing the cancer community on the concept of tumor angiogenesis (Folkman, 1974).
  • A review of the "two-hit hypothesis" of carcinogenesis, which posited that cancer is caused not only by activating mutations but also by the inactivation of "antioncogenes"— the genetic basis for understanding cancer etiology (Knudson, 1985).

Cancer Immunology Research: Exploring the Newest Frontier of Cancer Science

While celebrating its primary role in the history of cancer research, the AACR continued to define the rapidly expanding frontiers of cancer immunology and immunotherapy through its newest journal, Cancer Immunology Research. Led by new Editors-in-Chief Robert D. Schreiber, PhD, and Philip D. Greenberg, MD, the journal was ranked 20th out of 213 oncology journals with regard to impact factor in its fourth year of publication.

AACR Journals Online

As part of its commitment to the most effective dissemination of high-quality cancer science worldwide, the AACR migrated to a platform that improved the readability and ease of navigation for all of its journals in 2016. Interest in the online journals continued to increase, as journal articles were viewed nearly 71 million times in 2016.

Editors-in-Chief

Karen E. Knudsen, PhD, editor-in-chief of the AACR journal Molecular Cancer Research. Launched in 2002, Molecular Cancer Research defines the molecular basis of malignancy and progression.

The AACR thanks its editors-in-chief for their hard work and stewardship of its scientific publishing program.

Cancer Discovery

Lewis C. Cantley, PhD, FAACR

Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College
New York, New York

José Baselga, MD, PhD, FAACR

Memorial Sloan Kettering Cancer Center
New York, New York

Cancer Epidemiology, Biomarkers & Prevention

Timothy R. Rebbeck, PhD

Dana-Farber Cancer Institute
Boston, Massachusetts

Cancer Immunology Research

Robert D. Schreiber, PhD

Washington University School of Medicine
St. Louis, Missouri

Philip D. Greenberg, MD

Fred Hutchinson Cancer Research Center
Seattle, Washington

Cancer Prevention Research

Scott M. Lippman, MD

UC San Diego Moores Cancer Center
San Diego, California

Cancer Research

George C. Prendergast, PhD

Lankenau Institute for Medical Research
Wynnewood, Pennsylvania

Clinical Cancer Research

Kenneth C. Anderson, MD, FAACR

Dana-Farber Cancer Institute
Boston, Massachusetts

Molecular Cancer Research

Karen E. Knudsen, PhD

Kimmel Cancer Center
Philadelphia, Pennsylvania

Molecular Cancer Therapeutics

Napoleone Ferrara, MD, FAACR

UC San Diego Moores Cancer Center
San Diego, California

Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01 Image 01